Dynavox Group AB header image

Dynavox Group AB

DYVOX

Equity

ISIN SE0017105620 / Valor 114900704

NASDAQ Nordic Exchange Stockholm, Equities (2026-03-27)

SEK 82.05-4.54%

Dynavox Group AB
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Dynavox Group AB is a Swedish technology company specializing in augmentative and alternative communication (AAC) solutions for individuals with speech and communication impairments. The company develops and manufactures speech-generating devices, software applications, and related accessories designed to facilitate effective communication for people with conditions such as autism, cerebral palsy, and other disabilities. Dynavox serves a global market, providing tailored solutions that enhance the independence and quality of life for its users. In addition to its product offerings, the company offers training and support services to ensure effective implementation and use of its technologies in various settings, including educational institutions, healthcare facilities, and home environments.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

27.6%1Y

223%3Y

%5Y

Performance

49.5%1Y

43.9%3Y

44.4%5Y

Volatility

914 M

Market cap (USD)

1,171,652

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc Valor: 23194616

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 131.87

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

-7.98%USD 18.16

GE Healthcare Technologies Inc

GE Healthcare Technologies Inc Valor: 123735674

Annual Return

-50%0%+50%

Risk level

110

-3.23%USD 69.23

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-1.73%USD 27.27

Boiron SA

Boiron SA Valor: 487646

Annual Return

-50%0%+50%

Risk level

110

1.56%EUR 26.00

Laboratorios Farmaceuticos Rovi, SA

Laboratorios Farmaceuticos Rovi, SA Valor: 3591807

Annual Return

-50%0%+50%

Risk level

110

-0.57%EUR 78.90

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

-0.10%CHF 312.50

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc Valor: 33395434

Annual Return

-50%0%+50%

Risk level

110

-1.56%USD 510.68

Evotec SE

Evotec SE Valor: 505433

Annual Return

-50%0%+50%

Risk level

110

-1.60%EUR 4.30

Limes Schlosskliniken AG

Limes Schlosskliniken AG Valor: 38625581

Annual Return

-50%0%+50%

Risk level

110

-0.83%EUR 476.00

SIX

FactSet

Clearbit

Logos provided by Clearbit